Belen Garijo

Chief Executive Officer, Sanofi

Appointed as Chief Executive Officer on May 1, 2026, Belén Garijo is leading Sanofi into its next phase of growth by advancing its scientific roadmap, strengthening execution, and fostering a culture of excellence. She brings deep scientific expertise and a strong track record of sustainable results at the intersection of R&D, strategy, and business model transformation.

Previously, Belén served as Chair of the Executive Board and Chief Executive Officer of Merck, holding various positions within the company since joining in 2011. Before joining Merck, she served as a Senior Vice President of Global Operations Europe at Sanofi-Aventis, where she led the integration of Genzyme following its acquisition. She has also held several leadership positions in R&D and commercial development within the healthcare sector.

Belén is a physician specializing in clinical pharmacology. She began her career as a practicing physician at La Paz Hospital in Madrid, Spain.

Most Popular

Health and Healthcare Systems

ジェンダー不平等を拡大する介護の在り方を浮き彫りにした、新型コロナウイルス

新型コロナウイルスの大流行により介護の必要性が増し、予期せぬ大きな課題が提起される中、介護者を認識し、評価し、性差による偏向を減らしていくことの緊急性が高まっています。特に、リソースが限られ、患者の多くが入院できない状況において、新型コロナウイルスの患者とその家族にとって、緩和ケアおよび終末期ケアは必要性の高いものとなると考えられます。

18 May 2020

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2026 World Economic Forum